Jonathan Goldman
Director, Avalo Therapeutics, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$0.2M
Companies
1
Latest trade
Nov 14, 2025
Companies
Avalo Therapeutics, Inc.Director −$0.2M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.